Meta menu:

From here, you can access the Emergencies page, Contact Us page, Accessibility Settings, Language Selection, and Search page.

Open Menu

Cyberknife-treatment spectrum

Thanks to the flexibility of the robot, the Cyberknife can reach almost all parts of the body.

In particular, very irregularly shaped tumors can be located in sensitive brain regions without damage to healthy organs such as e.g. the visual or auditory nerve are treated.

In many cases, Cyberknife treatment can be used as an alternative to surgery or several weeks of radiation therapy.

You are here:

Which tumors can be treated at Cyberknife?

Tumors are very treatable with the Cyberknife if the relatively stringent indication criteria for radiosurgery are met.

  1. Depending on the location, the lesion to be treated should not exceed a certain size (optimal up to 3 cm, maximum of 6 cm) and well delinable in imaging, such as MRI (magnetic resonance imaging) or PET-CT (positron emission tomography) be.
  2. For the treatment on the cyberknife always a CT (computed tomography) examination for the planning of the irradiation is necessary.
  3. The treatment should also make sense in the overall oncological concept.

In addition to malignant tumors, some benign diseases can also be meaningfully treated by cyberknife.

Overview of all diseases treated with Cyberknife

  • Brain: brain metastases, acoustic neuroma (vestibular schwannoma), meningioma, arteriovenous malformation (AVM), trigeminal neuralgia, pituitary adenoma,
  • Spine / spinal cord: bone metastases, intraspinal metastases, meningioma, neurinoma
  • Lungs: early lung cancer, pulmonary metastases
  • Prostate: localized prostate cancer, prostate cancer Local recurrence, lymph node and bone metastases in limited numbers (oligometastasis)
  • Kidney / adrenals: kidney and adrenal metastases, selected cases of renal cell carcinoma
  • Liver: Liver metastases, selected cases of hepatocellular carcinoma (HCC)
  • Pancreas: selected cases of pancreatic carcinoma
  • Head / Neck: Skull base tumors, selected recurrences of ENT tumors